Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001178913-25-000110
Filing Date
2025-01-14
Accepted
2025-01-14 17:02:10
Documents
118

Document Format Files

Seq Description Document Type Size
1 S-1/A zk2532549.htm   iXBRL S-1/A 5754345
2 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 3235
3 EXHIBIT 23.2 exhibit_23-2.htm EX-23.2 3774
9 GRAPHIC image0.jpg GRAPHIC 394107
10 GRAPHIC image1.jpg GRAPHIC 719720
11 GRAPHIC image2.jpg GRAPHIC 696772
12 GRAPHIC image3.jpg GRAPHIC 315577
13 GRAPHIC image4.jpg GRAPHIC 566080
14 GRAPHIC image5.jpg GRAPHIC 622547
15 GRAPHIC image6.jpg GRAPHIC 1028065
16 GRAPHIC image7.jpg GRAPHIC 187927
17 GRAPHIC slxn_img01.jpg GRAPHIC 38245
  Complete submission text file 0001178913-25-000110.txt   31420925

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE slxn-20240930.xsd EX-101.SCH 149041
5 XBRL CALCULATION FILE slxn-20240930_cal.xml EX-101.CAL 41998
6 XBRL DEFINITION FILE slxn-20240930_def.xml EX-101.DEF 607982
7 XBRL LABEL FILE slxn-20240930_lab.xml EX-101.LAB 1289421
8 XBRL PRESENTATION FILE slxn-20240930_pre.xml EX-101.PRE 712213
121 EXTRACTED XBRL INSTANCE DOCUMENT zk2532549_htm.xml XML 3350705
Mailing Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606
Business Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606 972-8-6286005
Silexion Therapeutics Corp (Filer) CIK: 0002022416 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-282932 | Film No.: 25530096
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)